MedStar Georgetown University Hospital, Lombardi Comprehensive Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 20007.
Crixeo Health Trust Score: 60/100 (FAIR). This profile has not yet been claimed by the site owner.
MedStar Georgetown University Hospital, Lombardi Comprehensive Cancer Center has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast Carcinoma.
Sponsors: Georgetown University, Kartos Therapeutics, Inc..
Trust Score: 60/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
MedStar Georgetown University Hospital, Lombardi Comprehensive Cancer Center has a Crixeo Trust Score of 60/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
MedStar Georgetown University Hospital, Lombardi Comprehensive Cancer Center has 2 clinical trials on record, with 1 currently active. Their work covers Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast Carcinoma.
MedStar Georgetown University Hospital, Lombardi Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.